Drugs

Role of Apheresis in Rheumatoid Arthritis
pp. 1903-1908(6)
Author: Roth, Sanford H.

Optimising Antiresorptive Therapies in Postmenopausal Women: Why Do We Need to Give Due Consideration to the Degree of Suppression?
pp. 1909-1918(10)
Authors: Karsdal, Morten A.; Qvist, Per; Christiansen, Claus; Tankó, László B.

Novel Therapies for the Treatment of Small-Cell Lung Cancer: A Time for Cautious Optimism?
pp. 1919-1931(13)
Authors: Board, Ruth E.; Thatcher, Nick; Lorigan, Paul

B-Cell-Targeted Therapy for Systemic Lupus Erythematosus
pp. 1933-1948(16)
Authors: Sabahi, Ramin; Anolik, Jennifer H.

Familial Dyslipidaemias: An Overview of Genetics, Pathophysiology and Management
pp. 1949-1969(21)
Authors: Hachem, Sahar B.; Mooradian, Arshag D.

Cardiovascular Risk in Patients with HIV Infection: Impact of Antiretroviral Therapy
pp. 1971-1987(17)
Author: Bente Magny Bergersen,

Vildagliptin
pp. 1989-2001(13)
Authors: Henness, Sheridan; Keam, Susan J.

Vildagliptin: A Viewpoint by Marc Evans
pp. 2002-2004(3)
Author: Evans, Marc

Vildagliptin: A Viewpoint by Michelle V. Gordon and Anna C. Calkin
pp. 2002-2004(3)
Authors: Gordon, Michelle V.; Calkin, Anna C.

Vildagliptin: A Viewpoint by Alan J. Garber
pp. 2002-2004(3)
Author: Garber, Alan J.

Panitumumab: In the Treatment of Metastatic Colorectal Cancer
pp. 2005-2014(10)
Authors: Hoy, Sheridan M.; Wagstaff, Antona J.

Panitumumab: A Viewpoint by Imtiaz Malik
pp. 2015-2016(2)
Author: Malik, Imtiaz

Panitumumab: A Viewpoint by Malcolm Ranson
pp. 2015-2016(2)
Author: Ranson, Malcolm

Tramadol Extended-Release Tablets
pp. 2017-2027(11)
Authors: Hair, Philip I.; Curran, Monique P.; Keam, Susan J.

Tramadol Extended-Release Tablets: A Viewpoint by Mellar P. Davis
pp. 2028-2030(3)
Author: Davis, Mellar P.

Tramadol Extended-Release Tablets: A Viewpoint by Carolyn J. Sachs
pp. 2028-2030(3)
Author: Sachs, Carolyn J.

Tramadol Extended-Release Tablets: A Viewpoint by Bill H. McCarberg
pp. 2028-2030(3)
Author: McCarberg, Bill H.